BACKGROUND AND PURPOSE: Marfan syndrome, a connective tissue disorder caused by mutations in FBN1 encoding fibrillin-1, results in life-threatening complications in the aorta, but little is known about its effects in resistance vasculature. EXPERIMENTAL APPROACH: Second-order mesenteric arteries from mice at 3, 6 and 10 months of age (n= 30) heterozygous for the Fbn1 allele encoding a cysteine substitution (Fbn1(C1039G/+)) were compared with those from age-matched control littermates. KEY RESULTS: Stress-strain curves indicated that arterial stiffness was increased at 6 and 10 months of age in Marfan vessels. Isometric force measurement revealed that contraction in response to potassium (60 mM)-induced membrane depolarization was decreased by at least 28% in Marfan vessels at all ages, while phenylephrine (3 microM)-induced contraction was reduced by at least 40% from 6 months. Acetylcholine-induced relaxation in Marfan vessels was reduced to 70% and 45% of control values, respectively, at 6 and 10 months. Sensitivity to sodium nitroprusside was reduced at 6 months (pEC(50)= 5.64 +/- 0.11, control pEC(50)= 7.34 +/- 0.04) and 10 months (pEC(50)= 5.99 +/- 0.07, control pEC(50)= 6.99 +/- 0.14). Pretreatment with N(omega)-Nitro-L-arginine methyl ester (200 microM) had no effect on acetylcholine-induced relaxation in Marfan vessels, but reduced vasorelaxation in control vessels to 57% of control values. Addition of indomethacin (10 microM) and catalase (1000 U.mL(-1)) further inhibited vasorelaxation in Marfan vessels to a greater degree compared with control vessels. CONCLUSIONS AND IMPLICATIONS: Pathogenesis of Marfan syndrome in resistance-sized arteries increases stiffness and impairs vasomotor function.
BACKGROUND AND PURPOSE:Marfan syndrome, a connective tissue disorder caused by mutations in FBN1 encoding fibrillin-1, results in life-threatening complications in the aorta, but little is known about its effects in resistance vasculature. EXPERIMENTAL APPROACH: Second-order mesenteric arteries from mice at 3, 6 and 10 months of age (n= 30) heterozygous for the Fbn1 allele encoding a cysteine substitution (Fbn1(C1039G/+)) were compared with those from age-matched control littermates. KEY RESULTS: Stress-strain curves indicated that arterial stiffness was increased at 6 and 10 months of age in Marfan vessels. Isometric force measurement revealed that contraction in response to potassium (60 mM)-induced membrane depolarization was decreased by at least 28% in Marfan vessels at all ages, while phenylephrine (3 microM)-induced contraction was reduced by at least 40% from 6 months. Acetylcholine-induced relaxation in Marfan vessels was reduced to 70% and 45% of control values, respectively, at 6 and 10 months. Sensitivity to sodium nitroprusside was reduced at 6 months (pEC(50)= 5.64 +/- 0.11, control pEC(50)= 7.34 +/- 0.04) and 10 months (pEC(50)= 5.99 +/- 0.07, control pEC(50)= 6.99 +/- 0.14). Pretreatment with N(omega)-Nitro-L-arginine methyl ester (200 microM) had no effect on acetylcholine-induced relaxation in Marfan vessels, but reduced vasorelaxation in control vessels to 57% of control values. Addition of indomethacin (10 microM) and catalase (1000 U.mL(-1)) further inhibited vasorelaxation in Marfan vessels to a greater degree compared with control vessels. CONCLUSIONS AND IMPLICATIONS: Pathogenesis of Marfan syndrome in resistance-sized arteries increases stiffness and impairs vasomotor function.
Authors: Xiaohua Jiang; Fan Yang; Hongmei Tan; Dan Liao; Robert M Bryan; Jaspreet K Randhawa; Rolando E Rumbaut; William Durante; Andrew I Schafer; Xiaofeng Yang; Hong Wang Journal: Arterioscler Thromb Vasc Biol Date: 2005-10-06 Impact factor: 8.311
Authors: José M González; Ana M Briones; Barry Starcher; M Victoria Conde; Beatriz Somoza; Craig Daly; Elisabet Vila; Ian McGrath; M Carmen González; Silvia M Arribas Journal: Exp Physiol Date: 2005-05-12 Impact factor: 2.969
Authors: Arthur J A Leloup; Cor E Van Hove; Ammar Kurdi; Sofie De Moudt; Wim Martinet; Guido R Y De Meyer; Dorien M Schrijvers; Gilles W De Keulenaer; Paul Fransen Journal: J Physiol Date: 2016-08-02 Impact factor: 5.182
Authors: Joseph A Camarda; Ronak J Dholakia; Hongfeng Wang; Margaret M Samyn; Joseph R Cava; John F LaDisa Journal: Front Pediatr Date: 2022-05-04 Impact factor: 3.569
Authors: Jason Z Cui; Kevin C Harris; Koen Raedschelders; Zsuzsanna Hollander; James E Potts; Astrid De Souza; Marla Kiess; Bruce M McManus; Pascal Bernatchez; Leslie A Raffin; Heidi Paine; Cornelis van Breemen; George G S Sandor; Mitra Esfandiarei Journal: CJC Open Date: 2020-12-28